CAS: 577953-88-9 - Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)

Fórmula: C₃₅H₃₆ClNO₃S·C₁₂H₂₃N

InChI: InChI=1S/C35H36ClNO3S.C12H23N/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);11-13H,1-10H2/b15-10+;/t32-;/m1./s1

Chave InChI: InChIKey=ZLOLVGQQYDQBMP-HKHDRNBDSA-N

SMILES: O=C(O)CC1(CSC(C=2C=CC=C(C=CC=3N=C4C=C(Cl)C=CC4=CC3)C2)CCC=5C=CC=CC5C(O)(C)C)CC1.N(C1CCCCC1)C2CCCCC2

Sinónimos:

• 2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid dicyclohexylamine salt
• Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, compd. with N-cyclohexylcyclohexanamine (1:1)
• DCHA Salt, Montelukast dicyclohexylamine Salt
• Montelukast dicyclohexylamine salt

Montelukast racemate CRS

CAS: 577953-88-9

• Fórmula: C₃₅H₃₆ClNO₃S
• Peso molecular: 586.1832

Montelukast dicyclohexylamine

CAS: 577953-88-9

• Fórmula: C₄₇H₅₉ClN₂O₃S
• Pureza: 99.8%
• Cor e Forma: Beige
• Peso molecular: 766.39349

Montelukast Dicyclohexylamine

CAS: 577953-88-9

Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) …

• Fórmula: C₃₅H₃₆ClNO₃S·C₁₂H₂₃N
• Cor e Forma: White Powder
• Peso molecular: 585.21044

Montelukast Dicyclohexylamine Salt

CAS: 577953-88-9

• Fórmula: C₄₇H₅₉ClN₂O₃S
• Pureza: 97%
• Cor e Forma: Solid
• Peso molecular: 767.5010

Montelukast Dicyclohexylamine

CAS: 577953-88-9

• Fórmula: C₃₅H₃₆ClNO₃S·C₁₂H₂₃N
• Cor e Forma: Neat
• Peso molecular: 767.50

Montelukast dicyclohexylamine

CAS: 577953-88-9

Montelukast (MK0476), a selective CysLT1 antagonist, treats asthma, liver injury, and is researched for COVID-19.

• Fórmula: C₄₇H₅₉ClN₂O₃S
• Cor e Forma: Liquid
• Peso molecular: 767.5

Montelukast for System Suitability RS

CAS: 577953-88-9

• Cor e Forma: White Solid Powder

Montelukast Dicyclohexylamine RS

CAS: 577953-88-9

• Cor e Forma: White Solid Powder

Montelukast Dicyclohexylamine Salt

CAS: 577953-88-9

• Fórmula: C₃₅H₃₆ClNO₃S·C₁₂H₂₃N
• Cor e Forma: Neat
• Peso molecular: 767.50

Montelukast dicyclohexylamine

CAS: 577953-88-9

Montelukast is a leukotriene receptor antagonist that is used as an anti-inflammatory agent. It is …

• Fórmula: C₄₇H₅₉ClN₂O₃S
• Pureza: Min. 95%
• Cor e Forma: Powder
• Peso molecular: 767.5 g/mol